Canadian Glycomics Network

Category: Success Stories

GlycoNet startup Avivo awarded $10.9 M to advance technology for universal blood and organs

GlycoNet startup Avivo awarded $10.9 M to advance technology for universal blood and organs

Avivo was one of five companies selected for funding under the Government of Canada’s Life Sciences Fund to advance dual-use innovations and strengthen Canada’s industrial capacity.

Glycomics in Action: Powering the Next Wave of Biotech Breakthroughs

Glycomics in Action: Powering the Next Wave of Biotech Breakthroughs

In the most recent issue of BIOTECanada’s Insights Magazine, we talk about how Canada’s glycomics ecosystem is helping move complex sugar science from the lab into real-world solutions for health, biomanufacturing, and biosecurity.

AdvanCell and GlycoNet-supported startup 48Hour Discovery announce collaboration and exclusive licensing agreement

AdvanCell and GlycoNet-supported startup 48Hour Discovery announce collaboration and exclusive licensing agreement

48Hour Discovery partners with AdvanCell to advance a peptide-based Lead-212 radioligand therapy program for oncology.

GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs

GlycoNet startup Avivo achieves world’s first blood type A-to-O kidney transplant, a breakthrough for universal donor organs

The successful transplant marks major progress towards more compatible, accessible organs for patients.

Scroll to Top